Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Payables (2017 - 2025)

Bioceres Crop Solutions' Payables history spans 7 years, with the latest figure at $245.1 million for Q2 2024.

  • For Q2 2024, Payables changed N/A year-over-year to $245.1 million; the TTM value through Jun 2024 reached $245.1 million, changed N/A, while the annual FY2024 figure was $245.1 million, N/A changed from the prior year.
  • Payables for Q2 2024 was $245.1 million at Bioceres Crop Solutions, up from $166.0 million in the prior quarter.
  • Across five years, Payables topped out at $245.1 million in Q2 2024 and bottomed at $2.7 million in Q4 2021.
  • The 4-year median for Payables is $111.6 million (2020), against an average of $117.7 million.
  • The largest YoY upside for Payables was 13.82% in 2020 against a maximum downside of 13.82% in 2020.
  • A 4-year view of Payables shows it stood at $57.3 million in 2020, then plummeted by 95.31% to $2.7 million in 2021, then surged by 6076.2% to $166.0 million in 2022, then skyrocketed by 47.66% to $245.1 million in 2024.
  • Per Business Quant, the three most recent readings for BIOX's Payables are $245.1 million (Q2 2024), $166.0 million (Q2 2022), and $2.7 million (Q4 2021).